BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 17932975)

  • 1. Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes.
    Banwell B; Bar-Or A; Cheung R; Kennedy J; Krupp LB; Becker DJ; Dosch HM;
    Ann Neurol; 2008 Jan; 63(1):98-111. PubMed ID: 17932975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
    Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
    Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets.
    Rodriguez-Calvo T; Johnson JD; Overbergh L; Dunne JL
    Front Immunol; 2021; 12():667989. PubMed ID: 33953728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
    Durinovic-Belló I
    Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis.
    Mexhitaj I; Nyirenda MH; Li R; O'Mahony J; Rezk A; Rozenberg A; Moore CS; Johnson T; Sadovnick D; Collins DL; Arnold DL; Gran B; Yeh EA; Marrie RA; Banwell B; Bar-Or A
    Brain; 2019 Mar; 142(3):617-632. PubMed ID: 30759186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-antigen expression in the peripheral immune system: roles in self-tolerance and type 1 diabetes pathogenesis.
    Fuhlbrigge R; Yip L
    Curr Diab Rep; 2014; 14(9):525. PubMed ID: 25030265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal T-cell autoreactivity is amplified in overweight children with new-onset insulin-requiring diabetes.
    Buryk MA; Dosch HM; Libman I; Arena VC; Huang Y; Cheung RK; Trucco M; Pietropaolo M; Becker DJ
    Diabetes Care; 2015 Jan; 38(1):43-50. PubMed ID: 25414154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune tolerance and control of CNS autoimmunity: from animal models to MS patients.
    Cassan C; Liblau RS
    J Neurochem; 2007 Feb; 100(4):883-92. PubMed ID: 17181557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
    Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
    J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune T cell responses in the central nervous system.
    Goverman J
    Nat Rev Immunol; 2009 Jun; 9(6):393-407. PubMed ID: 19444307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple Sclerosis and T Lymphocytes: An Entangled Story.
    Legroux L; Arbour N
    J Neuroimmune Pharmacol; 2015 Dec; 10(4):528-46. PubMed ID: 25946987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of innate immune responses in autoimmune disease development.
    Waldner H
    Autoimmun Rev; 2009 Mar; 8(5):400-4. PubMed ID: 19162250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; nonimmunized nonobese diabetic mice can develop autoimmune encephalitis.
    Winer S; Astsaturov I; Cheung R; Gunaratnam L; Kubiak V; Cortez MA; Moscarello M; O'Connor PW; McKerlie C; Becker DJ; Dosch HM
    J Immunol; 2001 Feb; 166(4):2831-41. PubMed ID: 11160351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term evolution of autoreactive T cell repertoire in multiple sclerosis.
    Vergelli M; Mazzanti B; Traggiai E; Biagioli T; Ballerini C; Parigi A; Konse A; Pellicanò G; Massacesi L
    J Neurosci Res; 2001 Nov; 66(3):517-24. PubMed ID: 11746371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes.
    Baker RL; Rihanek M; Hohenstein AC; Nakayama M; Michels A; Gottlieb PA; Haskins K; Delong T
    Diabetes; 2019 Sep; 68(9):1830-1840. PubMed ID: 31175101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and spectrum of autoimmunity.
    Perl A
    Methods Mol Biol; 2012; 900():1-9. PubMed ID: 22933062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes.
    Oling V; Reijonen H; Simell O; Knip M; Ilonen J
    Cell Immunol; 2012; 273(2):133-9. PubMed ID: 22270037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
    Lee DH; Linker RA
    Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ expansion of T cells that recognize distinct self-antigens sustains autoimmunity in the CNS.
    Ramadan A; Lucca LE; Carrié N; Desbois S; Axisa PP; Hayder M; Bauer J; Liblau RS; Mars LT
    Brain; 2016 May; 139(Pt 5):1433-46. PubMed ID: 27000832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.